AI assistant
PFIZER INC — Director's Dealing 2010
Dec 23, 2010
29831_dirs_2010-12-23_9ee58845-97be-48a5-b7df-a8fa1da8f18f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2010-12-13
Reporting Person: Germano Geno J (Business Unit President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 134891.0000 | Direct |
| Common Stock | 1587.0000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Units | $ | Common Stock (3760.0000) | Direct | ||
| Stock Appreciation Rights | $17.6900 | 2015-02-25 | Common Stock (83333.0000) | Direct |
Footnotes
F1: I hereby disclaim beneficial ownership of all shares held by members of my family.
F2: These units, which were acquired pursuant to the Wyeth Supplemental Employee Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
F3: Each unit represents one phantom share of common stock.
F4: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.